Page 5 - Dexcom Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dexcom company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dexcom Company Profile Today - Breaking & Trending Today

DexCom, Inc. (NASDAQ:DXCM) Given Average Rating of "Moderate Buy" by Analysts

DexCom, Inc. (NASDAQ:DXCM) Given Average Rating of "Moderate Buy" by Analysts
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , Matthew Vincent Dolan , Michael Jon Brown , Raymond James , Dexcom Inc , Securities Exchange Commission , Canaccord Genuity Group , Royal Bank , Dexcom Company Profile , Turtle Creek Wealth Advisors , Cerity Partners , Partners Investment Advisory , Get Free Report , Marketbeat Ratings , Jon Brown , Exchange Commission , Vincent Dolan , Street Partners Investment Advisory , Get Free , Dexcom Share , Dexcom Real Time , Dexcom Daily ,

Ifrah Financial Services Inc. Decreases Stock Position in DexCom, Inc. (NASDAQ:DXCM)

Ifrah Financial Services Inc. Decreases Stock Position in DexCom, Inc. (NASDAQ:DXCM)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Jeremem Sylvain , Raymond James , Ifrah Financial Services Inc , Hm Payson Co , Valley National Advisers Inc , Partners Investment Advisory , Royal Bank , Stableford Capital , Securities Exchange Commission , Dexcom Inc , Canaccord Genuity Group , Wealth Advisors , Dexcom Company Profile , Exchange Commission , Ifrah Financial Services , Free Report , Financial Services , National Advisers , Street Partners Investment Advisory , Get Free Report , Dexcom Share , Dexcom Real Time , Visit Holdingschannel , Dexcom Daily ,

DexCom (NASDAQ:DXCM) Given New $160.00 Price Target at Raymond James

DexCom (NASDAQ:DXCM) Given New $160.00 Price Target at Raymond James
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Matthew Vincent Dolan , Kevinr Sayer , Raymond James , Commonwealth Equity Services , Dexcom Inc , Slatestone Wealth , Securities Exchange Commission , Royal Bank , Dexcom Company Profile , Principal Financial Group Inc , China Universal Asset Management Co , Canaccord Genuity Group , Free Report , Genuity Group , Moderate Buy , Get Free Report , Exchange Commission , Vincent Dolan , Equity Services , Financial Group , Universal Asset Management , Dexcom Share , Dexcom Real Time , Dexcom Daily ,

DexCom (NASDAQ:DXCM) PT Raised to $145.00

DexCom (NASDAQ:DXCM – Get Free Report) had its price objective raised by equities researchers at Canaccord Genuity Group from $144.00 to $145.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the medical device company’s stock. Canaccord Genuity Group’s price target points to a potential upside of […] ....

United States , Raymond James , Michael Jon Brown , Matthew Vincent Dolan , Norges Bank , Securities Exchange Commission , Capital Research Global Investors , Royal Bank , Artisan Partners Limited Partnership , Canaccord Genuity Group , Dexcom Company Profile , Massachusetts Financial Services Co , Dexcom Inc , Get Free Report , Genuity Group , Jon Brown , Exchange Commission , Vincent Dolan , World Investors , Partners Limited Partnership , Research Global Investors , Massachusetts Financial Services , Dexcom Share , Dexcom Real Time , Dexcom Daily , Nasdaq Dxcm ,

Raymond James Increases DexCom (NASDAQ:DXCM) Price Target to $160.00

DexCom (NASDAQ:DXCM – Get Free Report) had its target price lifted by research analysts at Raymond James from $151.00 to $160.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has a “strong-buy” rating on the medical device company’s stock. Raymond James’ price target points to a potential upside of 28.68% from […] ....

United States , Raymond James , Kevinr Sayer , Raymond Jame , Capital Partners , Royal Bank , Dexcom Inc , Canaccord Genuity Group , Smithfield Trust Co , Securities Exchange Commission , Riverview Trust Co , Mv Capital Management Inc , Valley National Advisers Inc , Dexcom Company Profile , Get Free Report , Genuity Group , Exchange Commission , National Advisers , Dexcom Share , Dexcom Real Time , Dexcom Daily , Nasdaq Dxcm , Boost Price Target ,